loading

Finanzdaten der Aileron Therapeutics Inc-Aktie (ALRN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
1.17%
7.205
7.29 1.983 1.992 5.011
Operating Income/Loss
1.17%
-7.205
-7.29 -1.983 -1.992 -5.011
Income/Loss From Continuing Operations Before Tax
3.08%
-7.113
-7.339 -1.827 -1.787 -4.779
Income/Loss From Continuing Operations After Tax
3.08%
-7.113
-7.339 -1.827 -1.787 -4.779
Net Income/Loss
3.08%
-7.113
-7.339 -1.827 -1.787 -4.779
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
14,326%
8.3018
0.0575 4.5412 4.5412 4.5412
Diluted Average Shares
14,326%
8.3018
0.0575 4.5412 4.5412 4.5412
Basic Earnings Per Share
45.22%
-0.86
-1.57 -0.40 -0.39 -1.05
Diluted Earnings Per Share
45.22%
-0.86
-1.57 -0.40 -0.39 -1.05
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):